Meyer Handelman Company’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.89M Hold
3,369
0.06% 131
2025
Q4
$2.28M Hold
3,369
0.07% 125
2025
Q3
$2.15M Sell
3,369
-622
-16% -$378K 0.07% 129
2025
Q2
$2.14M Hold
3,991
0.07% 130
2025
Q1
$1.68M Hold
3,991
0.06% 139
2024
Q4
$1.65M Hold
3,991
0.06% 140
2024
Q3
$2.02M Hold
3,991
0.07% 137
2024
Q2
$1.94M Hold
3,991
0.07% 137
2024
Q1
$2.15M Buy
+3,991
New +$2.18M 0.08% 129
2023
Q4
Sell
-3,994
Closed -$1.75M 195
2023
Q3
$1.75M Buy
+3,994
New +$1.99M 0.07% 134

Other funds holding IDXX

Meyer Handelman Company's IDXX Position: Q1 2026 in Review

Meyer Handelman Company held its Idexx Laboratories (IDXX) position steady in Q1 2026 at 3,369 shares worth $1.89M. The position accounts for 0.06% of the portfolio, ranked #131.

Meyer Handelman Company first reported a position in IDXX in Q3 2023 and has held it in 10 quarters since. The position peaked at $2.28M in Q4 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Meyer Handelman Company held 3,369 shares of Idexx Laboratories worth $1.89M as of Q1 2026.
  • Meyer Handelman Company left its Idexx Laboratories share count unchanged in Q1 2026.
  • Idexx Laboratories made up 0.06% of Meyer Handelman Company's portfolio in Q1 2026, its #131 holding.
  • Meyer Handelman Company first reported a position in Idexx Laboratories in Q3 2023 and has held it in 10 quarters since.
  • Meyer Handelman Company's Idexx Laboratories position peaked at $2.28M in Q4 2025.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Meyer Handelman Company's 13F filing for Q1 2026, filed 20 Apr 2026.